Mqupin Lidocaine Gel-patch
NDC Package 83781-014-06
Package Information
Mqupin Lidocaine Gel-patch (lidocaine gel-patch) patches is adults and Children above 12 years old 1.Clean and dry the skin. This formulation utilizes a patch delivery system. Marketed by Zhengzhou Miaoqi Medical Technology Co., Ltd., this product is identified by NDC 83781-014 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1649008 - lidocaine 4 % / menthol 3 % Medicated Patch
- RxCUI: 1649008 - lidocaine 0.04 MG/MG / menthol 0.03 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83781 - Zhengzhou Miaoqi Medical Technology Co., Ltd.
- 83781-014 - Mqupin Lidocaine Gel-patch
- 83781-014-06 - 50 PATCH in 1 BOX
- 83781-014 - Mqupin Lidocaine Gel-patch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (83781-014). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83781-014-06 identifies a specific commercial package of 50 patch in 1 box of Mqupin Lidocaine Gel-patch, a human over the counter drug labeled by Zhengzhou Miaoqi Medical Technology Co., Ltd.. This patch is formulated for topical use and contains lidocaine; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zhengzhou Miaoqi Medical Technology Co., Ltd. on January 28, 2026. The current certification is valid through December 31, 2027.
How is this Zhengzhou Miaoqi Medical Technology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83781001406. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.